Administration of recombinant human growth hormone normalizes GH-IGF1 axis and improves malnutrition-related disorders in patients with anorexia nervosa.

Hashizume K, Suzuki S, Komatsu A, Hiramatsu K, Mori J, Yamazaki M, Takeda T, Kakizawa T, Miyamoto T, Koizumi Y, Ichikawa K

Endocrine journal6 Mar 2007Cited by 11 (Europe PMC)

PMID17339748DOI10.1507/endocrj.k05-178PepBankPUB-17339748

Publisher page PubMedAsk about this study

Retracted· 12 Aug 2009Reported by Europe PMC and Retraction Watch (Crossref)

The journal or the authors withdrew this study after publication. Read the notice for the reason. PepBank keeps the study listed. Its results never count as key results, in evidence counts or in charts.

Retraction notice on PubMed (PMID 19706993) (opens in a new tab)Retraction notice, Europe PMC, seen 27 Oct 2026

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

No results listed for this study

This study is retracted. Results from a retracted study never count as evidence.

Read at the source

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

Version 2Current
27 Oct 2026, 16:37 UTC
Status changed: status, notices · status retracted · status notice from Retraction Watch (Crossref)
Version 1
27 Oct 2026, 16:36 UTC
First added · status retracted · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.